The hotel bar buzzed with the low hum of post-conference conversations. Delegates from around the world, fresh from a day of sessions on “The Rise and Fall of COVID-19,” nursed their drinks and swapped stories. At a quiet corner table, two figures leaned in, deep in discussion. Dr. Boris Petrov, a world-renowned epidemiologist, and Kakou Tanaka, a globe-trotting entrepreneur with companies on every continent, were about to discover a new way to think about innovation.
A Surprising Parallel
Boris swirled his drink, reflecting on the day’s presentations. “It’s fascinating,” he said, “how the spread of COVID-19 mirrored the spread of ideas in organizations. Both follow patterns, both face resistance, and both need the right conditions to really take off.”
Kakou, whose latest breakthrough—a new carbon capture technology—had struggled to gain traction across his businesses, was intrigued. “Are you saying I should treat innovation like a virus?”
Boris smiled. “In some ways, yes. Epidemiology, at its core, is about understanding how things spread through populations. Replace ‘virus’ with ‘new idea,’ and ‘public’ with ‘employees,’ and you have a powerful framework for managing change.”
The Innovation Epidemiology Model
Boris pulled out his notebook and drew a simple diagram: S-E-I-R.
- Susceptible (S): Teams open to new ideas but not yet exposed.
- Exposed (E): Teams aware of the idea but not yet acting.
- Infected/Adopters (I): Teams actively using the innovation.
- Recovered/Immune (R): Teams that tried and abandoned the idea, or are resistant.
“In a pandemic, we track how people move between these states. In your company, you can do the same with innovation. Who’s open? Who’s experimenting? Who’s resisting?”
Kakou nodded. “So, I need to map the ‘innovation health’ of my organization.”
“Exactly,” Boris said. “And just like with COVID-19, early detection and targeted intervention are key.”
Surveillance and Early Detection
Boris explained how, during the pandemic, countries with robust surveillance systems identified outbreaks early and responded quickly. “You need a corporate early warning system. Monitor where the new idea is being discussed, piloted, or ignored. Use employee feedback, internal forums, and project updates as your ‘testing kits.’”
Kakou realized that his company’s innovation dashboard tracked adoption rates, but not the underlying attitudes or barriers. “We’ve been measuring outputs, not readiness or resistance.”
“That’s your first lesson from epidemiology,” Boris said. “Understand the landscape before you act.”
Contact Tracing: Finding the Innovation Influencers
“In public health, we use contact tracing to find out who’s spreading the virus,” Boris continued. “In your company, you need to find your ‘innovation super-spreaders’—those employees who connect teams, share ideas, and influence others.”
Kakou thought of a few key staffers who always seemed to be at the center of new projects. “They’re not always managers, but everyone listens to them.”
“Exactly. Target your efforts through them. If they buy in, others will follow. But remember: some influencers are good at sparking interest, others at sustaining change. Know the difference.”
Geographic and Cultural Barriers
Boris pulled up a map on his phone. “COVID-19 spread differently in different regions—because of geography, culture, and infrastructure. Your global offices are the same. What works in Singapore might flop in São Paulo.”
Kakou saw the parallel. “So, I need to understand the ‘innovation geography’ of my company—where the barriers and accelerators are.”
“Right,” Boris said. “And just as countries learned from each other during the pandemic, your offices can share what works and what doesn’t. Create channels for that knowledge to flow.”
Pilot Programs: The Innovation Test Beds
“During COVID-19, pilot programs—like targeted lockdowns or early vaccine rollouts—helped us learn fast. In your company, pilots are your ‘innovation labs.’ Start with teams that are ready and resourced. Learn what works, then adapt for others.”
Kakou realized that some of his most successful projects started with small, enthusiastic teams before scaling up. “We need to formalize that process—use data from pilots to inform the wider rollout.”
“Exactly,” Boris said. “And don’t just copy-paste. Adapt based on local conditions.”
Adaptive Scaling: Learning and Spreading
Boris described how, during the pandemic, public health measures were constantly tweaked based on new data. “Do the same with your innovation. Use feedback from pilots to refine your approach. Then, use successful teams as hubs to spread the idea to others.”
Kakou saw how this could help avoid the pitfalls of one-size-fits-all rollouts. “We’ll scale by learning, not just by expanding.”
Communication: Mass Media and Peer Networks
“Epidemiology taught us that mass communication—press conferences, public service announcements—raises awareness. But real behavior change comes through trusted relationships: doctors, community leaders, family.”
Boris advised Kakou to combine top-down communication (company-wide emails, leadership announcements) with peer-to-peer advocacy (team champions, informal networks). “Your employees need to hear about the new idea from people they trust, not just from HQ.”
Kakou agreed. “Our best rollouts happened when local leaders became advocates.”
Building Innovation Immunity
“One of the biggest lessons from COVID-19 was herd immunity—when enough people are protected, the whole community is safer. In your company, you want ‘innovation immunity’—a culture where change is normal, and new ideas spread easily.”
Boris explained that this requires more than training or incentives. “You need to build the organizational ‘antibodies’—skills, habits, and networks that make your company resilient to stagnation and open to new ideas.”
Kakou saw the value. “If we build that culture, each new innovation will be easier to adopt.”
Stickiness: Making Ideas Last
Boris referenced the concept of “stickiness”—why some ideas catch on and others fade. “During the pandemic, simple, memorable messages worked best. In your company, innovations need to be easy to understand, try, and see in action.”
He listed the key factors:
- Relative Advantage: Clear benefits over current practices.
- Compatibility: Fits with existing values and workflows.
- Complexity: Simple enough to grasp and use.
- Trialability: Easy to test without big risks.
- Observability: Success is visible to others.
“If your innovation meets these criteria, it’s more likely to stick.”
Community Engagement: Employees as Partners
Boris emphasized the power of engagement. “The best public health campaigns involved communities in designing solutions. In your company, involve employees early—let them adapt the innovation to their needs.”
Kakou realized that some of his most successful initiatives were those where employees had a voice. “We need to treat them as partners, not just recipients.”
“Exactly,” Boris said. “Create feedback loops between headquarters and local teams. Blend expert knowledge with frontline experience.”
The Innovation Epidemiology Playbook
As the evening wound down, Boris summarized their discussion:
- Map the Landscape: Track which teams are susceptible, exposed, adopting, or resistant.
- Identify Influencers: Find and empower innovation super-spreaders.
- Pilot and Learn: Start small, adapt quickly, and use data to inform scaling.
- Communicate Smartly: Combine mass messages with peer advocacy.
- Build Culture: Foster habits and networks that make change normal.
- Engage Employees: Involve teams in shaping and sustaining innovation.
Kakou was energized. “We’ve been treating innovation as a technical problem. But it’s really about how ideas spread through people.”
Boris smiled. “That’s the epidemiological perspective. Track it, learn from it, and shape it deliberately.”
A New Field Emerges
Months later, Kakou’s carbon capture technology had found enthusiastic adoption across his global companies, guided by the principles discussed that night. Boris, meanwhile, began advising other organizations on applying epidemiological thinking to innovation.
Their conversation in the hotel bar sparked a new way of thinking—a fusion of public health science and business strategy. In a world where the ability to innovate quickly and effectively is more important than ever, the lessons of epidemiology offer a powerful roadmap for spreading new ideas, overcoming resistance, and building organizations that thrive on change.
Space for thoughts and ideas 
Leave a comment